GET THE LATEST UPDATES
Receive the latest event information about key speakers, sponsorship opportunities and exhibiting.
November 9-11, 2020 | Virtual Conference
Jim Carey is Executive Director, US Health Policy at Merck and Co., Inc., where he serves as US policy lead for Merck’s Biosimilars, Diabetes, HIV and Hepatitis C franchises, as well as market access policies under the ACA, federal Medicaid policy, and multiple other areas.
Jim also serves as the Treasurer of The Biosimilars Forum, an organization founded to inform and support public policies that encourage awareness, access, and adoption of biosimilars in the United States.
Prior to coming to Merck in 2014, Jim was Vice President and Head of US Corporate Policy for Novartis Corporation, also in Washington, DC. His responsibilities included directing the Public Policy agenda for the Novartis Group Companies in the US, ensuring coordination and collaboration across all US business units.
Jim is a 37-year veteran of the pharmaceutical industry, and he has spent the last 32 years in the government affairs and health policy arena.